Remove 2024 Remove Healthcare Remove Networking Remove Sales
article thumbnail

LogiPharma Europe 2024: Delivering Agility in Supply Chains Through Building Multimodal Cold Chain Networks

Pharmaceutical Commerce

In an interview with Pharma Commerce Editor Nicholas Saraceno, Cathy O'Brien, VP of Sales, UPS Healthcare discusses her masterclass on delivering agility in supply chains by building a multimodal cold chain network while also reducing risks at LogiPharma Europe 2024.

article thumbnail

How to Land a Job in Pharmaceutical Sales for 2024 and Beyond

Contrarian Sales Techniques

So, you've got your sights set on the pharmaceutical sales world for 2024, huh? Why choose pharma sales job? Breaking into pharma sales is like trying to get backstage at a sold-out concert (think Cold Play for Malaysians). Details on the difference between Medical Devices sales to Pharma sales ) Your toolkit?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How health plans can leverage competitive intelligence data today to drive impact in 2024

Clarify Health

The strategic use of competitive intelligence data is increasingly becoming a crucial factor for healthcare payers looking to make informed decisions around strategic market expansion and strengthen their market position.

article thumbnail

What a string of semaglutide biosimilars could mean for Mainland China

Clarivate

The company filed for marketing approval of their semaglutide biosimilar for the treatment of T2D with the National Medical Products Administration (NMPA) in April 2024, and this is expected to amplify clinical development of semaglutide biosimilars from domestic manufacturers in the next two to three years.

article thumbnail

Nine for 2023, part three: thriving or surviving?

pharmaphorum

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed. Medicines manufacturing is energy intensive.

article thumbnail

Welldoc Receives 10th 510(k) Clearance from FDA for Award-Winning Diabetes Platform BlueStar®

Legacy MEDSearch

This enhanced functionality will be made available commercially in 2024. Insulin dosing is a critical piece to diabetes management, and now, Welldoc’s software has the power to deliver these important data and insights directly into the hands of adults living with diabetes, their caregivers and their healthcare providers.”

FDA 52
article thumbnail

FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor

Legacy MEDSearch

Dexcom disclosed its plans to make Stelo available for purchase online without the need for a prescription, starting in summer 2024. The device relies on a wearable sensor, which communicates with a smartphone application to continuously monitor blood glucose levels providing valuable insight into users’ blood sugar fluctuations.